The Long-Term Efficacy of Radiofrequency Ablation With and Without Steroid Injection.

Q3 Medicine
Psychopharmacology bulletin Pub Date : 2020-10-15
Alaa Abd-Elsayed, Michael Loebertman, Peter Huynh, Ivan Urits, Omar Viswanath, Nalini Sehgal
{"title":"The Long-Term Efficacy of Radiofrequency Ablation With and Without Steroid Injection.","authors":"Alaa Abd-Elsayed,&nbsp;Michael Loebertman,&nbsp;Peter Huynh,&nbsp;Ivan Urits,&nbsp;Omar Viswanath,&nbsp;Nalini Sehgal","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Radiofrequency ablation (RFA) has been proven to be an effective option for treating chronic low back pain. In addition to RFA as a treatment modality, the administration of concomitantly to minimize the effect of hyperalgesia is common practice. However, there is insufficient evidence about the long-term outcomes of their use.</p><p><strong>Methods: </strong>This was a retrospective study that examined 239 patients who received spine, knee joint, and sacroiliac joint RFA between June 2014 and June 2018. Pre- and post-procedure pain scores, percent improvements, and duration of relief were included in our review.</p><p><strong>Subjects: </strong>This study included 239 patients of which 191 patients received steroids with their RFA.</p><p><strong>Results: </strong>These 191 patients experienced an average improvement of 48.48% relief for an average of 137.52 days. Forty-eight patients did not receive steroids with RFA and had an average improvement of 46.36% for an average of 126.10 days. The statistical analysis revealed there was no significant difference between the two groups for percent improvement (p = 0.71) and duration of relief (p = 0.67).</p><p><strong>Conclusions: </strong>Patients who received steroids with RFA compared to RFA alone did not differ significantly in percent improvement in pain and duration of relief.</p>","PeriodicalId":21069,"journal":{"name":"Psychopharmacology bulletin","volume":"50 4 Suppl 1","pages":"11-16"},"PeriodicalIF":0.0000,"publicationDate":"2020-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901125/pdf/PB-50-4S1-11.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychopharmacology bulletin","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Radiofrequency ablation (RFA) has been proven to be an effective option for treating chronic low back pain. In addition to RFA as a treatment modality, the administration of concomitantly to minimize the effect of hyperalgesia is common practice. However, there is insufficient evidence about the long-term outcomes of their use.

Methods: This was a retrospective study that examined 239 patients who received spine, knee joint, and sacroiliac joint RFA between June 2014 and June 2018. Pre- and post-procedure pain scores, percent improvements, and duration of relief were included in our review.

Subjects: This study included 239 patients of which 191 patients received steroids with their RFA.

Results: These 191 patients experienced an average improvement of 48.48% relief for an average of 137.52 days. Forty-eight patients did not receive steroids with RFA and had an average improvement of 46.36% for an average of 126.10 days. The statistical analysis revealed there was no significant difference between the two groups for percent improvement (p = 0.71) and duration of relief (p = 0.67).

Conclusions: Patients who received steroids with RFA compared to RFA alone did not differ significantly in percent improvement in pain and duration of relief.

注射类固醇和不注射类固醇的射频消融的长期疗效。
背景:射频消融(RFA)已被证明是治疗慢性腰痛的有效选择。除了RFA作为一种治疗方式外,通常的做法是同时给药以尽量减少痛觉过敏的影响。然而,关于使用它们的长期结果的证据不足。方法:这是一项回顾性研究,调查了2014年6月至2018年6月期间接受脊柱、膝关节和骶髂关节RFA的239例患者。术前和术后疼痛评分、改善百分比和缓解持续时间被纳入我们的回顾。受试者:本研究包括239例患者,其中191例患者在RFA时接受类固醇治疗。结果:191例患者平均改善48.48%,平均缓解137.52天。48例患者未接受RFA类固醇治疗,平均改善46.36%,平均126.10天。统计学分析显示两组在改善百分比(p = 0.71)和缓解持续时间(p = 0.67)方面无显著差异。结论:与单独接受RFA治疗的患者相比,接受RFA治疗的患者在疼痛改善百分比和缓解时间方面没有显著差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Psychopharmacology bulletin
Psychopharmacology bulletin PHARMACOLOGY & PHARMACY-PSYCHIATRY
CiteScore
2.70
自引率
0.00%
发文量
32
期刊介绍: Information not localized
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信